Serialisation Pharma: Reliable, Future-Proof, Cost-Efficient
Are you looking to comply with the EU Directive and other international regulations on protection against counterfeit medicines? And are you looking for a solution that will generate, manage and report serial numbers reliably? And, despite the pressure you are under – the EU Directive cut-off date is 09.02.2019 – would you like to make a forwardlooking, sustainable and economic decision?
Then G+D Currency Technology should be your first port of call. For the past 160 years we have been offering serialisation management to very demanding customers: central banks. Now we have translated this unique expertise to the specific requirements of pharmaceutical companies. The result is G+D Currency Solutions' software solution SeriTrack. It enables you to organise the serialisation of prescription pharmaceuticals not only smoothly, but cost-effectively and with an eye to the future.
We make the high quality standards of banknote serialisation available to the pharmaceuticals industry. It enables companies of all sorts of sizes to comply with complex global requirements. «
Save money with modular solutions
SeriTrack is a streamlined, demand-based solution developed specially for a wide range of international serialisation areas. Its modular structure makes it very quick and easy to adapt to your specific requirements. It requires little work or outlay to implement.
Making serialisation and Track&Trace future-proof
SeriTrack’s modern data structure makes it effortless and convenient to comply with statutory regulations in the EU, USA, Russia, Brazil, Saudi Arabia and other countries. And, equally importantly, this software solution is very easy to scale up to future tasks. Handling steadily growing quantities of data, implementing new processes (such as reworking and aggregation) and integrating new products are all plain sailing using SeriTrack.
Pitfalls in Serialization Backends
Act swiftly to ensure you begin serialisation in time
9 February 2019 and other important deadlines are drawing near. Act now to make sure you can still market your pharmaceuticals smoothly once the EU Directive and other international regulations come into force. Set up an appointment with us to advise you without obligation. Our experts are sure to identify the ideal solution for you.
Giesecke+Devrient Currency Technology GmbH
+49 89 4119-8277
Thank you for your message!
We will be in touch shortly.
To make sure we can contact you, we just sent you a confirmation email to the address you provided. Should you not receive anything, please checkout your spam-folder and make sure you entered your email address correctly.